EDGAR Filing Documents for 0001193125-11-158553

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:

SEC Accession No. 0001193125-11-158553

Filing Date

2011-06-03

Accepted

2011-06-03 17:11:38

Documents

Period of Report

2010-12-31

Document Format Files

Seq	Description	Document	Type	Size
1	ANNUAL REPORT ON FORM 20-F	d20f.htm	20-F	1638230
2	NOTICE AND ARTICLES AND ARTICLES OF THE COMPANY	dex11.htm	EX-1.1	169927
3	SUBSCRIPTION AGREEMENT	dex21.htm	EX-2.1	153006
4	SUBSCRIPTION AGREEMENT	dex22.htm	EX-2.2	119312
5	AMENDMENT NO. 1 TO THE AMENDED AND RESTATED AGREEMENT	dex41.htm	EX-4.1	80092
6	AMENDED AND RESTATED LICENSE AGREEMENT	dex42.htm	EX-4.2	584822
7	SUBLICENSE AGREEMENT	dex43.htm	EX-4.3	87416
8	AMENDED AND RESTATED LICENSE COLLABORATION AGREEMENT	dex44.htm	EX-4.4	425961
9	AMENDED AND RESTATED CROSS-LICENSE AGREEMENT	dex45.htm	EX-4.5	322504
10	LICENSE AGREEMENT	dex46.htm	EX-4.6	316527
11	SETTLEMENT AGREEMENT	dex47.htm	EX-4.7	225973
12	DEVELOPMENT, MANUFACTURING AND SUPPLY AGREEMENT	dex48.htm	EX-4.8	331013
13	EXECUTIVE EMPLOYMENT AGREEMENT WITH IAN MORTIMER	dex49.htm	EX-4.9	77338
14	EXECUTIVE EMPLOYMENT AGREEMENT WITH IAN MACLACLAN	dex410.htm	EX-4.10	293172
15	EXCECUTIVE EMPLOYMENT AGREEMENT WITH MARK MURRAY	dex411.htm	EX-4.11	169128
16	EXECUTIVE EMPLOYMENT AGREEMENT WITH PETER LUTWYCHE	dex412.htm	EX-4.12	79711
17	SHARE OPTION PLAN	dex413.htm	EX-4.13	111394
18	LEASE AGREEMENT	dex414.htm	EX-4.14	510833
19	FORM OF INDEMNITY AGREEMENT	dex415.htm	EX-4.15	35192
20	AWARD CONTRACT	dex416.htm	EX-4.16	206157
21	LICENSE AGREEMENT	dex417.htm	EX-4.17	162431
22	AMENDED AGREEMENT	dex418.htm	EX-4.18	34691
23	SECOND AMENDMENT AGREEMENT	dex419.htm	EX-4.19	84240
24	CONSENT AGREEMENT	dex420.htm	EX-4.20	108392
25	AMENDMENT NO. 2 TO THE AMENDED AND RESTATED AGREEEMNT	dex421.htm	EX-4.21	33105
26	LIST OF SUBSIDIARIES	dex81.htm	EX-8.1	2078
27	SECTION 302 CERTIFICATION OF CEO	dex121.htm	EX-12.1	8942
28	SECTION 302 CFO CERTIFICATION	dex122.htm	EX-12.2	8939
29	SECTION 906 CEO AND CFO CERTIFICATE	dex131.htm	EX-13.1	5347
30	CONSENT OF KPMG LLP	dex151.htm	EX-15.1	4500
31	GRAPHIC	g189874ex4_7pg029.jpg	GRAPHIC	174257
32	GRAPHIC	g189874g32c03.jpg	GRAPHIC	261874
33	GRAPHIC	g189874g69v40.jpg	GRAPHIC	6759
34	GRAPHIC	g189874img11.jpg	GRAPHIC	250179
35	GRAPHIC	g189874img22.jpg	GRAPHIC	154351
36	GRAPHIC	g189874tx_021.jpg	GRAPHIC	99056
	Complete submission text file	0001193125-11-158553.txt		7696307

Mailing Address 200-8900 GLENLYON PARKWAY BURNABY A1 V5J 5J8

Business Address 200-8900 GLENLYON PARKWAY BURNABY A1 V5J 5J8 604-419-3200

TEKMIRA PHARMACEUTICALS CORP (Filer) CIK: 0001447028 (see all company filings)